SNDL Reports Record Cash Flow, Launches Strategic Review of Cannabis Operations After $52 Million Impairment
The company reported C$238 million in third-quarter revenue and positive adjusted operating income, while expanding its investment in U.S. cannabis operator Parallel.
SNDL Inc. (NASDAQ: SNDL) reported record quarterly free cash flow of C$20 million on Tuesday, even as declining cannabis manufacturing revenue and a C$52 million goodwill impairment pushed the Canadian cannabis and liquor retailer to a C$48.3 million operating loss.
The company also announced a strategic review of its Cannabis Operations segment, including potential asset divestitures and productivity initiatives, as it seeks to improve the performance of its production business while increasing its exposure to the U.S. cannabis market.
For the quarter ended September 30, SNDL generated C$238 million in net revenue, down 2.5% from C$244.2 million a year earlier. Gross profit declined 9.8% to C$57.9 million, while gross margin contracted two percentage points to 24.3%.
Despite those declines, adjusted operating income improved to C$5.2 million from a C$9.5 million loss in the third quarter of 2025.
The improvement reflected stronger investment results, lower corporate expenses and resilient retail operations, although the company’s cannabis production segment remained unprofitable.
“Our third quarter results demonstrate improvement in SNDL’s underlying financial performance, including positive adjusted operating income and record quarterly free cash flow generation,” said CEO Zach George.
Cannabis Manufacturing Remains the Weakest Business
SNDL’s Cannabis Operations segment generated C$27 million in third-quarter revenue, down 27.7% from C$37.4 million a year earlier.
The segment recorded a negative gross margin of 6%, compared with a positive 13.4% in the prior-year period. Its adjusted operating loss widened to C$11.4 million from C$10.2 million.
Including impairment and restructuring charges, the segment’s operating loss reached C$64.7 million.
Management attributed much of the revenue decline to its exit from unprofitable domestic dried flower products and a shift toward higher-value categories.
However, the transition has also exposed inventory and manufacturing challenges.
The company recorded approximately C$6 million in additional negative impacts, primarily related to inventory adjustments and cost variances associated with its Jeeter products.
At its Kelowna manufacturing facility, SNDL reduced its workforce by more than 30% during the quarter as part of a broader effort to lower manufacturing and operating costs.
Management expects those reductions to begin contributing to financial results in the fourth quarter.
SNDL is now evaluating further changes to the business, including possible asset sales.
“Cannabis Operations remained below expectations and recorded a non-cash impairment,” George said.
The company is considering a range of strategic and operational alternatives, from divestitures to larger productivity initiatives, according to its earnings announcement.
The review introduces a potentially significant change to SNDL’s vertically integrated strategy. While the company continues to operate one of Canada’s largest cannabis retail networks, management is reassessing how much capital and operational capacity should remain committed to domestic production.
Cannabis Retail Returns to Revenue Growth
The company’s cannabis retail business delivered a comparatively stronger quarter.
Revenue increased 0.7% year over year to a record C$85.6 million, while gross profit rose 2.9% to C$23.1 million.
Gross margin reached 27%, up from 26.4% a year earlier, and operating income increased 3.9% to C$5.2 million.
Those gains came despite continued weakness in comparable-store sales.
Same-store cannabis retail sales declined 3.8%, reflecting contraction in SNDL’s largest provincial markets, Ontario and Alberta.
New store openings and Value Buds conversions helped offset the decline.
As of October 26, SNDL operated 193 cannabis retail locations under the Value Buds and Spiritleaf banners, including 133 Value Buds stores and 60 Spiritleaf locations.
The results suggest that expansion and improved margins are supporting overall retail performance, even as existing stores face softer market demand.
Ontario Regulatory Settlement Could Restart Franchise Expansion
SNDL also reported progress toward resolving regulatory matters involving the Alcohol and Gaming Commission of Ontario.
The anticipated resolution remains subject to definitive documentation and payment of a C$200,000 monetary penalty.
If finalized, the agreement is expected to allow the company’s Value Buds franchise network to resume expansion in Ontario after a pause lasting more than a year.
The contemplated structure would remove Ontario retail operations from SNDL’s consolidated financial statements while substantially preserving the company’s net economics associated with those franchise locations, according to management.
Parallel Investment Expands SNDL’s U.S. Exposure
Alongside its Canadian restructuring, SNDL continued increasing its economic exposure to U.S. cannabis operator Parallel.
Following Parallel’s restructuring in July, which reduced the company’s debt burden by approximately US$842 million, SNDL participated in a rights offering that increased its indirect equity ownership from approximately 67% to 92%.
The company also funded additional investments through SunStream Bancorp, including financing for a cultivation facility in Gainesville, Florida, and the purchase of additional Parallel debt. SunStream’s ownership of Parallel’s takeback debt increased from 39.4% to 69.4% following a purchase at 75% of face value. SNDL’s cannabis-related investment portfolio reached a carrying value of C$485.2 million at September 30, including C$467.7 million associated with SunStream.
The Investments segment generated C$7.9 million in operating income during the quarter, compared with C$1.5 million a year earlier.
Of that amount, C$6.9 million came from SNDL’s share of profits from equity-accounted investees, primarily reflecting an increase in Parallel’s valuation.
SNDL is also examining whether it can transition its indirect exposure to direct ownership and consolidation of qualifying U.S. medical cannabis operations.
Management indicated that adult-use operations would remain outside the contemplated consolidated structure and any transition would be subject to legal, regulatory, accounting, and Nasdaq requirements, but no definitive structure or timetable has been announced.
Record Free Cash Flow Comes With Important Qualifications
SNDL reported C$20 million in free cash flow for the quarter, up 19.5% from C$16.7 million in the comparable period last year.
However, the figure includes a C$10.6 million benefit associated with the initial unwinding of the company’s captive insurance arrangement.
Excluding that benefit, quarterly free cash flow would have been approximately C$9.4 million, although that calculation is not a company-reported adjusted measure.
The distinction is important when assessing the sustainability of cash generation: SNDL’s free cash flow is also a non-IFRS measure that excludes certain investment and financing cash flows. The company reported C$18.6 million in cash generated from operating activities, compared with C$31.7 million a year earlier.
Meanwhile, cash and cash equivalents declined by C$50.7 million during the quarter, reflecting substantial strategic investments and share repurchases.
SNDL contributed approximately C$60.8 million to equity-accounted investments and spent another C$10 million repurchasing common shares during the period, while the company ended September with C$132.5 million in cash and cash equivalents.
Management separately reported C$617.8 million in unrestricted cash, marketable securities and investments, including equity-accounted investees, and no outstanding debt.
These figures describe different measures of liquidity and financial resources. Consider also that the broader C$617.8 million amount includes investments that should not be treated as immediately available cash.
SNDL Considers Additional C$50 Million Share Buyback
SNDL also reiterated its intention to pursue a potential substantial issuer bid of up to C$50 million.
The contemplated offer would purchase shares at a price not exceeding C$1.92, or approximately US$1.35, per share.
If completed and fully subscribed at the maximum price, the transaction could reduce outstanding common shares by more than 10%, according to the company.
During the third quarter, SNDL repurchased 5.4 million common shares at a weighted average price of US$1.31 per share.
Through October 22, the company had repurchased approximately 23.1 million shares year to date, leaving 243.3 million outstanding.
A More Focused Business, With Several Moving Parts
SNDL’s third-quarter results highlight the different trajectories of its operating businesses.
Cannabis retail returned to modest revenue growth and improved margins, while liquor retail continued to generate operating income despite declining sales.
The Investments segment benefited from Parallel’s restructuring and valuation gains, providing an important contribution to adjusted operating results.
Cannabis manufacturing, however, remained a source of losses and required a significant impairment.
The strategic review creates the possibility of a smaller or more focused production business, while SNDL continues directing capital toward U.S. cannabis investments and shareholder repurchases.
The coming quarters will provide a clearer picture of whether the company’s restructuring can improve manufacturing economics, whether retail margins remain resilient, and how much of its reported cash generation can be sustained without exceptional benefits.
For investors, the central issue is how effectively SNDL can convert its substantial asset base and improving performance in selected business segments into consistent, recurring profitability.
SNDL’s latest results underscore the financial and strategic decisions facing cannabis operators as they balance profitability, capital allocation, restructuring and expansion into new markets. These challenges will be central to the conversation at IgniteIt’s Cannabis Capital & Policy Summit in Washington, D.C., on November 18, where industry executives, investors and policymakers will examine the investment strategies, regulatory developments and market forces shaping the next chapter of the cannabis industry.

